March 8, 2017 — Navidea Biopharmaceuticals announced the completion of the sale of its Lymphoseek product to Cardinal ...
March 3, 2017 — In the featured article of the March 2017 issue of The Journal of Nuclear Medicine, researchers ...
February 16, 2017 — Cerveau Technologies Inc. announced it has signed an agreement with Siemens’ PETNET Solutions Inc ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
February 7, 2017 — Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of ...
February 6, 2017 — A study published in the February issue of The Journal of Nuclear Medicine demonstrates the potential ...
January 30, 2017 — IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
January 17, 2017 — NorthStar Medical Technologies LLC has received additional matching funds from the U.S. Department of ...
January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source ...
January 6, 2017 — New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of ...
January 3, 2017 — Sirtex Medical Limited announced in December that SIR-Spheres Y-90 resin microspheres have been ...
December 28, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has developed United States ...
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and ...
December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on ...
Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be detected ...
November 2, 2016 — By the time unambiguous signs of memory loss and cognitive decline appear in people with Alzheimer’s ...
October 28, 2016 — The National Academies of Sciences, Engineering, and Medicine (NAS) have released a report on the ...
October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3 ...
October 17, 2016 — Lantheus Holdings Inc. announced in late September that sub-analysis data from the first Phase 3 ...
September 9, 2016 — The Alzheimer’s Disease Neuroimaging Initiative (ADNI) recently launched into its next phase, ADNI3 ...
September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA) ...
March 08, 2017 